In cancer patients, inflammatory changes indicate that IDO may be induced by soluble factors including IFNγ, TNF-α, IL-1β, soluble CD40 ligand (sCD40L) and CTLA-4 ligation to CD80/CD86 expressed by DC [5,32,33]. Here, CD86 is linked to cancer.